{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:16:01Z","timestamp":1794730561452,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hugh Green Foundation Chair in Addiction Research"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SAF-12345"],"award-info":[{"award-number":["SAF-12345"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Canada has been home to a longstanding public health crisis related to opioids, including an extensive mortality and morbidity toll in the face of substantive intervention gaps. Recently (2019), two extensive reports from preeminent federal authorities \u2013 the Chief Public Health Officer and the Mental Health Commission of Canada \u2013 have been tabled with detailed, core focus on the phenomenon of \u2018stigma\u2019 and its impacts on substance\/opioid use and harms. The reports present extensive descriptions of the nature and effects, as well as a multitude of prescriptions for remedial measures and actions to \u201cstop the cycle of stigma\u201d. Closer reading of the documents, however, suggests substantial conceptual and empirical limitations in the characterization of the \u2013 multi-faceted and challenging \u2013 nature and workings of \u2018stigma\u2019 as a socio-political, structural or individual process or force, specifically as it applies to and negatively affects substance use and related outcomes, primarily the wellbeing of substance users. Concretely, it is unclear how the remedial actions proposed will materially alleviate stigma process and impacts, especially given apparent gaps in the issues examined, including essential strategies \u2013 for example, reform of drug user criminalization as a fundamental element and driver of structural stigma - for action that directly relate to the jurisdictions and privileged mandates of the report sources themselves as health and policy leaders. The commentary provides some concrete while subjective notes and observations on the dynamics of stigma as applies to and framed for substance\/opioid use, as well as strategies and measures necessary to both tangibly address the material health and wellbeing of substance users, and related forces of stigma, in the distinct context of the opioid crisis in Canada.<\/jats:p>","DOI":"10.1186\/s13011-020-00294-2","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T13:02:04Z","timestamp":1598878924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Some notes on the use, concept and socio-political framing of \u2018stigma\u2019 focusing on an opioid-related public health crisis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2186-4030","authenticated-orcid":false,"given":"Benedikt","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"issue":"2","key":"294_CR1","first-page":"118","volume":"27","author":"L Vojtila","year":"2019","unstructured":"Vojtila L, Pang M, Goldman B, Kurdyak P, Fischer B. Non-medical opioid use, harms and interventions in Canada \u2013 a 10-year update on an unprecedented and unabating substance use-related public health crisis. Drugs: Educ Prev Policy. 2019;27(2):118\u201322.","journal-title":"Drugs: Educ Prev Policy"},{"issue":"5","key":"294_CR2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/ADM.0000000000000412","volume":"12","author":"T Gomes","year":"2018","unstructured":"Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. Measuring the burden of opioid-related mortality in Ontario, Canada. J Addict Med. 2018;12(5):418.","journal-title":"J Addict Med"},{"key":"294_CR3","volume-title":"Opioid-related harms in Canada","author":"Government of Canada","year":"2020","unstructured":"Government of Canada. Opioid-related harms in Canada. Ottawa: Government of Canada; 2020. Available from: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids\/. Retrieved on: 6 June 2020."},{"issue":"2","key":"294_CR4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.24095\/hpcdp.39.2.03","volume":"39","author":"M Orpana Heather","year":"2019","unstructured":"Orpana Heather M, Lang Justin J, George Diana HJ. At-a-glance: the impact of poisoning-related mortality on life expectancy at birth in Canada, 2000 to 2016. Health Promotion Chronic Dis Prev Canada: Res Policy Pract. 2019;39(2):56.","journal-title":"Health Promotion Chronic Dis Prev Canada: Res Policy Pract"},{"key":"294_CR5","volume-title":"Addressing stigma: towards a more inclusive health system","author":"Government of Canada","year":"2020","unstructured":"Government of Canada. Addressing stigma: towards a more inclusive health system. Ottawa: Public Health Agency of Canada; 2020. Available from: https:\/\/www.canada.ca\/en\/public-health\/corporate\/publications\/chief-public-health-officer-reports-state-public-health-canada\/addressing-stigma-toward-more-inclusive-health-system.html. Retrieved on: 6 June 2020."},{"key":"294_CR6","volume-title":"Stigma and the opioid crisis: final report","author":"Mental Health Commission of Canada","year":"2019","unstructured":"Mental Health Commission of Canada. Stigma and the opioid crisis: final report. Ottawa: Mental Health Commission of Canada; 2019."},{"issue":"549","key":"294_CR7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3399\/bjgp08X280092","volume":"58","author":"M Fitzpatrick","year":"2008","unstructured":"Fitzpatrick M. Stigma. Br J Gen Pract. 2008;58(549):294.","journal-title":"Br J Gen Pract"},{"issue":"6","key":"294_CR8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2850.2009.01399.x","volume":"16","author":"CA Ross","year":"2009","unstructured":"Ross CA, Goldner EM. Stigma, negative attitudes and discrimination towards mental illness within the nursing profession: a review of the literature. J Psychiatr Ment Health Nurs. 2009;16(6):558\u201367.","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"2","key":"294_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09595230500102434","volume":"24","author":"R Room","year":"2005","unstructured":"Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143\u201355.","journal-title":"Drug Alcohol Rev"},{"key":"294_CR10","first-page":"1195","volume-title":"Substance use stigma as a barrier to treatment and recovery. Addiction medicine","author":"JB Luoma","year":"2010","unstructured":"Luoma JB. Substance use stigma as a barrier to treatment and recovery. Addiction medicine. New York: Springer; 2010. p. 1195\u2013215."},{"key":"294_CR11","volume-title":"Managing the stigma of opioid use. Healthcare management forum","author":"H Stuart","year":"2019","unstructured":"Stuart H. Managing the stigma of opioid use. Healthcare management forum. Los Angeles: SAGE publications; 2019."},{"key":"294_CR12","unstructured":"The Hill Times. Naming stigma as a public health crisis is brave, bold, and necessary. Ottawa; 2020. Available: https:\/\/www.hilltimes.com\/2020\/02\/10\/naming-stigma-as-a-public-health-crisis-is-brave-bold-and-necessary\/233736. Retrieved on: June 6, 2020."},{"issue":"3","key":"294_CR13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2307\/1290411","volume":"100","author":"WJ Stuntz","year":"2001","unstructured":"Stuntz WJ. The pathological politics of criminal law. Mich Law Rev. 2001;100(3):505\u2013600.","journal-title":"Mich Law Rev"},{"issue":"2","key":"294_CR14","first-page":"467","volume":"93","author":"R Weisberg","year":"2002","unstructured":"Weisberg R. Norms and criminal law, and the norms of criminal law scholarship. J Crimial Law Criminol. 2002;93(2):467.","journal-title":"J Crimial Law Criminol"},{"issue":"4","key":"294_CR15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.drugpo.2005.04.005","volume":"16","author":"T Kerr","year":"2005","unstructured":"Kerr T, Small W, Wood E. The public health and social impacts of drug market enforcement: a review of the evidence. Int J Drug Policy. 2005;16(4):210\u201320.","journal-title":"Int J Drug Policy"},{"issue":"8","key":"294_CR16","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/S2352-3018(17)30073-5","volume":"4","author":"K DeBeck","year":"2017","unstructured":"DeBeck K, Cheng T, Montaner JS, Beyrer C, Elliott R, Sherman S, et al. HIV and the criminalisation of drug use among people who inject drugs: a systematic review. Lancet HIV. 2017;4(8):e357\u2013e74.","journal-title":"Lancet HIV"},{"key":"294_CR17","doi-asserted-by":"crossref","first-page":"c3439","DOI":"10.1136\/bmj.c3439","volume":"341","author":"T Rhodes","year":"2010","unstructured":"Rhodes T, Sarang A, Vickerman P, Hickman M. Policy resistance to harm reduction for drug users and potential effect of change. Br Med J. 2010;341:c3439.","journal-title":"Br Med J"},{"key":"294_CR18","unstructured":"The Hill Times. \u2018Canada\u2019s forgotten public health emergency\u2019: opioid crisis rages amid the ndemic, says former Harper aide. Ottawa; 2020. Available: https:\/\/www.hilltimes.com\/2020\/04\/15\/canadas-forgotten-public-health-emergency-opioid-crisis-rages-amid-the-pandemic-says-former-harper-aide\/243550. Retrieved on: June 6, 2020."},{"key":"294_CR19","unstructured":"Global News. With 3,996 opioid deaths in 1 year, Canada hasn\u2019t called a \u2018public health emergency.\u2019 Here\u2019s why Toronto;2018. Available from: https:\/\/globalnews.ca\/news\/4749514\/canada-opioid-crisis-solutions\/. Retrieved on: June 6, 2020."},{"issue":"1","key":"294_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-8205-z","volume":"20","author":"B Fischer","year":"2020","unstructured":"Fischer B, Jones W, Tyndall M, Kurdyak P. Correlations between opioid mortality increases related to illicit\/synthetic opioids and reductions of medical opioid dispensing-exploratory analyses from Canada. BMC Public Health. 2020;20(1):1\u20137.","journal-title":"BMC Public Health"},{"key":"294_CR21","doi-asserted-by":"crossref","first-page":"k3207","DOI":"10.1136\/bmj.k3207","volume":"362","author":"T Gomes","year":"2018","unstructured":"Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, et al. Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada. BMJ. 2018;362:k3207.","journal-title":"BMJ"},{"key":"294_CR22","doi-asserted-by":"crossref","unstructured":"Fischer B, Lee A, Vojtila L. \u2018Safer opioid distribution\u2019 as an essential public health intervention for the opioid mortality crisis\u2013considerations, options and models towards broad-based implementation. Public Health Pract. 2020;1.","DOI":"10.1016\/j.puhip.2020.100016"},{"key":"294_CR23","doi-asserted-by":"crossref","unstructured":"Fischer B, Pang M, Tyndall M. Applying principles of injury and infectious disease control to the opioid mortality epidemic in North America: critical intervention gaps. J Public Health. 2019. https:\/\/academic.oup.com\/jpubhealth\/article\/doi\/10.1093\/pubmed\/fdz162\/5671801.","DOI":"10.1093\/pubmed\/fdz162"},{"key":"294_CR24","volume-title":"Comparative law","author":"M Laurence","year":"1988","unstructured":"Laurence M, Snortum J, Zimring F. Social control of the drinking driver. In: Arzt G, editor. Comparative law. Chicago: The University of Chicago Press; 1988."},{"issue":"4","key":"294_CR25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/650349","volume":"83","author":"J Stuber","year":"2009","unstructured":"Stuber J, Galea S, Link BG. Stigma and smoking: the consequences of our good intentions. Soc Serv Rev. 2009;83(4):585\u2013609.","journal-title":"Soc Serv Rev"},{"issue":"6","key":"294_CR26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/casp.901","volume":"16","author":"C Campbell","year":"2006","unstructured":"Campbell C, Deacon H. Unravelling the contexts of stigma: from internalisation to resistance to change. J Community Appl Soc Psychol. 2006;16(6):411\u20137.","journal-title":"J Community Appl Soc Psychol"},{"issue":"1","key":"294_CR27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugalcdep.2018.04.024","volume":"189","author":"B Fischer","year":"2018","unstructured":"Fischer B, Varatharajan T, Shield K, Rehm J, Jones W. Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada. Drug Alcohol Depend. 2018;189(1):76\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"17\u201318","key":"294_CR28","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1503\/cmaj.160356","volume":"188","author":"B Fischer","year":"2016","unstructured":"Fischer B, Rehm J, Tyndall M. Effective Canadian policy to reduce harms from prescription opioids: learning from past failures. Can Med Assoc J. 2016;188(17\u201318):1240\u20134.","journal-title":"Can Med Assoc J"},{"issue":"2","key":"294_CR29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","volume":"99","author":"A Van Zee","year":"2009","unstructured":"Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221\u20137.","journal-title":"Am J Public Health"},{"issue":"5","key":"294_CR30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/03639045.2012.680468","volume":"39","author":"DJ Mastropietro","year":"2013","unstructured":"Mastropietro DJ, Omidian H. Current approaches in tamper-resistant and abuse-deterrent formulations. Drug Dev Ind Pharm. 2013;39(5):611\u201324.","journal-title":"Drug Dev Ind Pharm"},{"key":"294_CR31","doi-asserted-by":"crossref","unstructured":"Babor T, Caulkins J, Fischer B, Foxcroft D, Humphreys K, Medina-Mora M, et al. Drug policy and the public good (2nd edition). Oxford: Oxford University Press; 2018.","DOI":"10.1093\/oso\/9780198818014.001.0001"},{"key":"294_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S183252","volume":"10","author":"KA Crapanzano","year":"2019","unstructured":"Crapanzano KA, Hammarlund R, Ahmad B, Hunsinger N, Kullar R. The association between perceived stigma and substance use disorder treatment outcomes: a review. Subst Abuse Rehabil. 2019;10:1.","journal-title":"Subst Abuse Rehabil"},{"issue":"5","key":"294_CR33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/YCO.0000000000000351","volume":"30","author":"L Yang","year":"2017","unstructured":"Yang L, Wong LY, Grivel MM, Hasin DS. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatry. 2017;30(5):378.","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"294_CR34","first-page":"85","volume":"20","author":"C Lloyd","year":"2013","unstructured":"Lloyd C. The stigmatization of problem drug users: a narrative literature review. Drugs: Educ Prev Policy. 2013;20(2):85\u201395.","journal-title":"Drugs: Educ Prev Policy"},{"key":"294_CR35","doi-asserted-by":"crossref","unstructured":"Kulesza M, Larimer ME, Rao D. Substance use related stigma: what we know and the way forward. J Addictive Behaviors, Therapy Rehabil. 2013;2(2).","DOI":"10.4172\/2324-9005.1000106"},{"issue":"1\u20132","key":"294_CR36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC Van Boekel","year":"2013","unstructured":"Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1\u20132):23\u201335.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"294_CR37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","volume":"107","author":"JD Livingston","year":"2012","unstructured":"Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39\u201350.","journal-title":"Addiction."},{"issue":"4","key":"294_CR38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s40596-014-0067-1","volume":"38","author":"K Crapanzano","year":"2014","unstructured":"Crapanzano K, Vath RJ, Fisher D. Reducing stigma towards substance users through an educational intervention: harder than it looks. Acad Psychiatry. 2014;38(4):420\u20135.","journal-title":"Acad Psychiatry"},{"key":"294_CR39","volume-title":"Suitable enemy. Bianchi H, Swaaningen Rv, editors","author":"N Christie","year":"1986","unstructured":"Christie N. Suitable enemy. Bianchi H, Swaaningen Rv, editors. Amsterdam: Free University Press; 1986."},{"key":"294_CR40","unstructured":"Eastwood N, Fox E, Rosmarin A. A quiet revolution: drug decriminalisation policies in practice across the globe. United Kingdom: Release - Drugs, The Law & Human Rights; 2016."}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-020-00294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-020-00294-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-020-00294-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:04:31Z","timestamp":1627949071000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-020-00294-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1186\/s13011-020-00294-2","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"21 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}